Hosted on MSN1mon
Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drugCasgevy works by enabling people to produce a fetal form of hemoglobin that doesn't cause sickling. It does so by suppressing the gene BCL11A, which normally shuts down fetal hemoglobin production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback